期刊文献+

骨髓增生异常综合征的免疫表型和SURVIVIN、P15INK4B、TRF1基因表达 被引量:2

Immunophenotype and expressions of SURVIVIN,P15INK4B and TRF1 gene in myelodysplastic syndromes
下载PDF
导出
摘要 目的探讨骨髓增生异常综合征(MDS)特征性免疫表型,SURVIVIN、P15INK4B、TRF1基因表达程度,及其与临床病情进展的关系。方法抽取50例MDS患者骨髓细胞,用流式细胞学技术检测免疫表型;抽取单个核细胞,用RT-PCR方法检测SURVIVIN、P15INK4B、TRF1基因mRNA表达程度。结果与对照组相比,MDS患者骨髓细胞原始群CD7和CD34表达增多;粒细胞群CD34表达增多,CD13、CD33、CD11b表达下降;单核细胞表达CD117和CD34。与对照组相比,MDS患者骨髓单个核细胞SURVIVIN和TRF1基因mRNA表达增加,P15INK4B基因mR-NA表达下降(P均<0.05)。从低危组到高危组,SURVIVIN和TRF1基因mRNA表达增加,P15INK4B基因mRNA表达下降(P均<0.05)。结论 MDS免疫表型有其特征性,SURVIVIN、P15INK4B和TRF1基因表达可能与其发病进展有关。 Objective To explore the characteristic immunophenotype and SURVIVIN,P15INK4B and TRF1 gene of myelodysplastic syndromes(MDS),and the its relation with the progression of clinical condition.Methods Immunophenotype analysis was performed in 50 cases of MDS using flow cytometry(FCM).We evaluated the mRNA expression of SURVIVIN,P15INK4B and TRF1 in mononuclear cells of MDS bone marrow by reverse transcription-polymerase chain reaction(RT-PCR).Results Compared with the control group,CD7 and CD34 expressions in primary cell populations of bone marrow cell,CD34 expression in granule cell were increased,CD13,CD33,CD11b decreased in MDS patients.CD117 and CD34 expressed in monocytes.Compared with the control group,P15INK4B mRNA was decreased,but SURVIVIN and TRF1 increased.From low-risk group to the high-risk group,SURVIVIN and TRF1 mRNA expressions were increased,but P15INK4B decreased gradually.Conclusions Immunophenotype of MDS has its characteristic.Progress and incidence of MDS may have relation with SURVIVIN,P15INK4B,and TRF1 gene.
出处 《山东医药》 CAS 北大核心 2011年第33期1-3,共3页 Shandong Medical Journal
基金 江苏省"六大人才高峰"省级资助课题(2008-5)
关键词 骨髓增生异常综合征 免疫表型分型 SURVIVIN P15INK4B TRF1 myelodsplastic syndromes immunophenotyping SURVIVIN P15INK4B TRF1
  • 相关文献

参考文献8

二级参考文献31

  • 1Corey SJ, Minden MD, Barber DL, et al. Myelodysplastic syndromes: the complexity of stem-cell diseases. Nat Rev Cancer, 2007; 7:118-129.
  • 2Mohamedali A, Gaken J, Twine NA, et al. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. Blood,2007; 110:3365 - 3373.
  • 3Harada H, Harada Y. Point mutation in the AML1/RUNX1 gene associated with myelodysplastic syndrome. Crit Rev Eukaryot Gene Expr,2005 ; 15 : 183 - 196.
  • 4Niimi H, Harada H, Harada Y, et al. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations. Leukemia, 2006 ; 20 : 635 - 644.
  • 5Campbell PJ, Baxter EJ, Beer PA, et al. Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, eytogenetic associations, and role in leukemic transformation. Blood, 2006; 108:3548 - 3555.
  • 6Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 1997 ; 89:2079 - 2088.
  • 7Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon : IARCPress. 2008 : 87 - 103.
  • 8Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with the outcome after hematopoietic stem cell transplantation. Blood, 2003 ; 102:394 - 340.
  • 9Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 2002 ; 100:2292 - 2302.
  • 10Kuriyama K, Tomonaga M, Matsuo T, et al. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and micro-megakaryocytes in myelodysplastic syndrome. Br J Haematol, 1986 ; 63:665 - 669.

共引文献24

同被引文献18

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部